TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
REPL

Replimune Group Inc

Healthcare · Biotechnology

12.90$ -1.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow REPL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-0.23 -0.52 -1.09 -1.77 -1.33 -1.57 -2.20 -2.79 -2.39 -3.02
0.00 0.00 0.01 0.02 0.04 0.04 0.04 0.04 0.04 0.04
0.01 0.03 0.12 0.23 0.25 0.46 0.48 0.51 0.43 0.35
0.01 0.05 0.36 0.23 0.28 0.51
0.00 0.06 -0.05 -0.45 0.08 0.14 0.26 0.08 0.30 -0.04
0.01 0.00 0.11 0.19 0.05 0.04 0.04 0.09 0.08 0.05
-0.01 -1.43 -2.84 -0.15 -4.08 -0.03 -2.45 1.46 -0.30 3.35
0.82 1.98
0.49 1.78 4.37 0.82 1.98 1.59
0.32 0.32 0.43 0.29 -0.23 -0.01 0.48 0.22 -0.01 0.37
0.49 1.78 4.37 2.92 8.05 0.13 5.35 0.24 3.13 0.71
0.20 -0.10 0.40 1.00 2.66 -1.47 0.70 -1.08 0.46 1.05
-0.24 -0.52 -1.21 -1.96 -1.38 -1.62 -2.24 -2.87 -2.47 -3.07

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?